Showing results (341-350 of 24,499) with videos related to
Sort By:
Pageof 2,450
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Compounds for Treating Huntington's DiseaseRam W SabnisACS Medicinal Chemistry Letters|August 20, 2025
Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS DisordersRam W SabnisACS Medicinal Chemistry Letters|August 20, 2025
Novel Non-hallucinogenic Neurite Growth Compounds as 5‑HT2A Agonists for Treating Stress-Related Disorders, Namely Depression, Anxiety, and PTSDRam W SabnisACS Medicinal Chemistry Letters|August 20, 2025
Novel Compounds as Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Novel Cyclopentapyrrole Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and HypersomniaRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as ARNT Degraders for Treating Cancer, in Particular, Hematological CancerRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory DiseasesRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as CX3CR1Modulators for Treating Cardiovascular DiseasesRam W SabnisACS Medicinal Chemistry Letters|February 19, 2025
Novel Carbocyclic Phenylpyrrolidinone Urea Compounds as FPR2 Agonists for Treating Atherosclerosis and Heart FailureRam W SabnisACS Medicinal Chemistry Letters|November 20, 2024
Bicyclic Ureas as JAK2 Inhibitors for Treating Hematological CancerRam W SabnisPageof 2,450